Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glucosaminic Acid SCHEMBL5290846 | 1.00 | USP2 (1.00) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Glucosaminic Acid SCHEMBL7642316 | 1.00 | USP2 (1.00) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Glucosaminic Acid SCHEMBL30955946 | 1.00 | USP2 (1.00) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Glucosaminic Acid SCHEMBL13984380 | 1.00 | USP2 (1.00) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Glucosaminic Acid SCHEMBL17830012 | 1.00 | USP2 (1.00) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Glucosaminic Acid SCHEMBL13010965 | 1.00 | USP2 (1.00) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Glucosaminic Acid SCHEMBL27248833 | 0.96 | USP2 (0.91) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL812543 | 0.93 | USP2 (0.86) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL7148984 | 0.93 | USP2 (0.86) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| Galactitol SCHEMBL9487119 | 0.85 | USP2 (0.73) | USP2SLCO1B1PDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 678 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| EP-3958831-B1 | PREBIOTIC SKIN CARE COMPOSITIONS CONTAINING CARBOXYLIC ACIDS | UNIV GENT (BE) | 2025-02-26 | — | — | EP | claimed |
| US-12226503-B2 | Prebiotic skin care compositions containing carboxylic acids | UNIVERSITEIT GENT (BE) | 2025-02-18 | — | — | US | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| WO-2024069235-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2024-04-04 | — | — | WO | claimed |
| US-20230322837-A1 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2023-10-12 | — | — | US | claimed |
| EP-4253394-A1 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. (CN) | 2023-10-04 | — | — | EP | claimed |
| US-20230137741-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC | 2023-05-04 | — | — | US | claimed |
| CN-1183786-A | Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition | MENARINI FARMA IND (IT) | 1998-06-03 | — | — | CN | claimed |
| EP-0815126-A1 | BICYCLIC TACHYKININS ANTAGONISTS, PREPARATION THEREOF AND THEIR USE IN PHARMACEUTICAL COMPOSITION | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1998-01-07 | — | — | EP | claimed |
| WO-1996040861-A1 | MICROBIOLOGICAL MEDIA FOR ISOLATION AND IDENTIFICATION OF ENTERIC PATHOGENS SUCH AS E. COLI AND SALMONELLA | BIOLOG, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996028467-A1 | BICYCLIC TACHYKININS ANTAGONISTS, PREPARATION THEREOF AND THEIR USE IN PHARMACEUTICAL COMPOSITION | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1996-09-19 | — | — | WO | claimed |
| US-5191016-A | Functionalized poly(hydroxyalkanoates) and method of manufacturing same | YALPANI MANSSUR (US) | 1993-03-02 | — | — | US | claimed |
| EP-0292087-B1 | IMPROVED REDUCING AGENT AND METHOD FOR THE ELECTROLESS DEPOSITION OF SILVER | LONDON LABORATORIES LIMITED (US) | 1992-05-20 | — | — | EP | claimed |
| CN-1016365-B | IMPROVED REDUCING AGENT AND METHOD FOR ELECTROLESS DEPOSITION OF SILVER | LONDON LABORATORIES (US) | 1992-04-22 | — | — | CN | claimed |
| CN-88100308-A | The improvement reductive agent and the method for electroless deposition of silver | — | 1988-12-07 | — | — | CN | claimed |
| EP-0292087-A2 | Improved reducing agent and method for the electroless deposition of silver | LONDON LABORATORIES LIMITED (US) | 1988-11-23 | — | — | EP | claimed |
| US-4737188-A | USING AN HYDROXYAMINE REDUCING AGENT | LONDON LABORATORIES LIMITED (US) | 1988-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12226503-B2 | Prebiotic skin care compositions containing carboxylic acids | CUTA, TYR, DSC1 | USP2 1077/4885SLCO1B1 1848/4885PDE4A 1001/4885 |
| US-20230322837-A1 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | PROC, TMPRSS2, ACE2 | USP2 2873/4885SLCO1B1 4813/4885PDE4A 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.